ScholarWorks@Gyeongsang National University

Browsing by Ahn, Jin SeokAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 11 of 11

SCIESCOPUS
A Phase 1/2 Study of Lazertinib 240 mg in Patients With Advanced EGFR T790M-Positive NSCLC After Previous EGFR Tyrosine Kinase Inhibitors

Cho, Byoung Chul; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Cho, Eun Kyung; Lee, Yun-Gyoo; Kim, Dong-Wan; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok, et al.

ArticleIssue Date2022CitationJournal of Thoracic Oncology, v.17, no.4, pp 558 - 567PublisherElsevier Inc.
SCISCIESCOPUS
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics

Han, Hye-Suk; Lee, Ki Hyeong; Lee, Kyung Hee; Ryu, Jeong Seon; Kim, Young Chul; Park, Seung Woo; Oh, Ho-Suk; Park, Kyung Tae; Kwon, Jung Hye; Lee, Pyung Bok, et al.

ArticleIssue Date2014CitationSUPPORTIVE CARE IN CANCER, v.22, no.3, pp 741 - 750PublisherSPRINGER
SCIESCOPUSKCI
A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13open access

Yoo, Kwai Han; Lee, Su Jin; Cho, Jinhyun; Lee, Ki Hyeong; Park, Keon Uk; Kim, Ki Hwan; Cho, Eun Kyung; Choi, Yoon Hee; Kim, Hye Ryun; Kim, Hoon-Gu, et al.

ArticleIssue Date2019CitationCANCER RESEARCH AND TREATMENT, v.51, no.2, pp 718 - 726PublisherKOREAN CANCER ASSOCIATION
SCISCIESCOPUS
A randomized, phase II study of vandetanib maintenance for advanced or metastatic non-small-cell lung cancer following first-line platinum-doublet chemotherapy

Ahn, Jin Seok; Lee, Ki Hyeong; Sun, Jong-Mu; Park, Keunchil; Kang, Eun-Suk; Cho, Eun Kyung; Lee, Dae Ho; Kim, Sang-We; Lee, Gyeong-Won; Kang, Jin-Hyoung, et al.

ArticleIssue Date2013CitationLUNG CANCER, v.82, no.3, pp 455 - 460PublisherELSEVIER IRELAND LTD
SCOPUSESCI
Clinical Outcomes of Maintenance Durvalumab After Definitive Concurrent Chemoradiotherapy in Unresectable Locally Advanced Stage III NSCLC According to EGFR and ALK Status: Korean Cancer Study Group LU-22-18open access

Choi, Dae-Ho; Kim, Miso; Kim, Young Saing; Park, Keon Uk; Cho, Jang Ho; Kim, Hongsik; Lee, Ki Hyeong; Ahn, Heejoon; Kim, Il-Hwan; Lee, Kyung-Hee, et al.

ArticleIssue Date2024CitationJTO Clinical and Research Reports, v.5, no.12PublisherElsevier Inc.
SCIESCOPUS
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study

Ahn, Myung-Ju; Han, Ji-Youn; Lee, Ki Hyeong; Kim, Sang-We; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Jong-Seok, et al.

ArticleIssue Date2019CitationLANCET ONCOLOGY, v.20, no.12, pp 1681 - 1690PublisherELSEVIER SCIENCE INC
SCISCIESCOPUS
Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.

Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Lee, Gyeong-won; Lee, Jong-Seok; Kim, Joo-Hang, et al.

ArticleIssue Date2019CitationJournal of Clinical Oncology, v.37, no.15PublisherAmerican Society of Clinical Oncology
SCISCIESCOPUS
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)open access

Sun, Jong-Mu; Lee, Ki Hyeong; Kim, Bong-Seog; Kim, Hoon-Gu; Min, Young Joo; Yi, Seong Yoon; Yun, Hwan Jung; Jung, Sin-Ho; Lee, Se-Hoon; Ahn, Jin Seok, et al.

ArticleIssue Date2018CitationBRITISH JOURNAL OF CANCER, v.118, no.5, pp 648 - 653PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With <i>EGFR</i>- or <i>ALK</i>-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)open access

Park, Sehhoon; Kim, Tae Min; Han, Ji-Youn; Lee, Gyeong-Won; Shim, Byoung Yong; Lee, Yun-Gyoo; Kim, Sang-We; Kim, Il Hwan; Lee, Suee; Kim, Yu Jung, et al.

ArticleIssue Date2024CitationJournal of Clinical Oncology, v.42, no.11, pp 1241 - 1251PublisherAmerican Society of Clinical Oncology
SCISCIESCOPUS
Sedation for terminally ill cancer patients A multicenter retrospective cohort study in South Koreaopen access

Kim, Young Saing; Song, Haa-Na; Ahn, Jin Seok; Koh, Su-Jin; Ji, Jun Ho; Hwang, In Gyu; Yun, Jina; Kwon, Jung Hye; Kang, Jung Hun

ArticleIssue Date2019CitationMedicine, v.98, no.5PublisherLippincott Williams & Wilkins Ltd.
SCIESCOPUS
Temporal patterns of chronic disease incidence after breast cancer: a nationwide population-based cohort studyopen access

Kang, Danbee; Kang, Minwoong; Hong, Yun Soo; Park, Jihwan; Lee, Jin; Seo, Hwa Jeong; Kim, Dong Wook; Ahn, Jin Seok; Park, Yeon Hee; Lee, Se Kyung, et al.

ArticleIssue Date2022CitationScientific Reports, v.12, no.1PublisherNature Publishing Group
1

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532

COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어